TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
NBAB, Nordic BioAnalysis AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
10,161
|
7,931
|
4,153 |
Financial expenses |
42
|
6
|
0 |
Earnings before taxes |
-322
|
-894
|
57 |
EBITDA |
-157
|
-974
|
101 |
Total assets |
5,609
|
4,992
|
5,312 |
Current assets |
4,850
|
4,626
|
5,051 |
Current liabilities |
2,988
|
2,411
|
1,731 |
Equity capital |
2,440
|
2,580
|
3,581 |
- share capital |
125
|
116
|
120 |
Employees (average) |
8
|
6
|
4 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
43.5%
|
51.7%
|
67.4% |
Turnover per employee |
1,270
|
1,322
|
1,038 |
Profit as a percentage of turnover |
-3.2%
|
-11.3%
|
1.4% |
Return on assets (ROA) |
-5.0%
|
-17.8%
|
1.1% |
Current ratio |
162.3%
|
191.9%
|
291.8% |
Return on equity (ROE) |
-13.2%
|
-34.7%
|
1.6% |
Change turnover |
1,667
|
3,902
|
-3,158 |
Change turnover % |
20%
|
97%
|
-43% |
Chg. No. of employees |
2
![]() |
2
|
0 |
Chg. No. of employees % |
33%
|
50%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.